Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC

Nan Bi1, Yu Wang1, Luhua Wang2

  • 1Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.

The Lancet. Oncology
|March 31, 2022
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos